Literature DB >> 16322401

Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas.

Dorthe Cartier1, Sylvie Jégou, Françoise Parmentier, Isabelle Lihrmann, Estelle Louiset, Jean-Marc Kuhn, Christian Bastard, Pierre-François Plouin, Michel Godin, Hubert Vaudry, Hervé Lefebvre.   

Abstract

OBJECTIVE: We aimed to investigate the expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenoma (APA) tissues in comparison with normal adrenal cortex. DESIGN AND METHODS: Total 5-HT4 receptor mRNAs were quantified by real-time quantitative polymerase chain reaction (PCR) assay, and the mRNAs encoding the 5-HT4 receptor isoforms were characterized by reverse transcription (RT)-PCR in seven normal adrenal cortices and 11 APA tissues. The distribution of 5-HT4 receptor mRNAs was investigated by in situ hybridization in both normal adrenal and APA tissues, and the presence of 5-HT in APA tissues was studied by immunohistochemistry.
RESULTS: Real-time PCR analysis revealed that 5-HT4 receptor mRNA expression was 4.7-47 times higher in APA tissues than in normal glands. In situ hybridization studies showed that 5-HT4 receptor mRNAs were expressed in both zona glomerulosa and zona fasciculata/reticularis of the normal cortex and in groups of APA steroidogenic cells disseminated in the tumor tissues. Characterization of 5-HT4 receptor splice variants by RT-PCR revealed different profiles of expression in APAs versus normal adrenals. Isoforms (a) and (b) were not expressed in any APA but were present in the majority of normal adrenocortical tissues. Conversely, isoform (d) was expressed in 5/11 APAs but only in 1/7 adrenals. Immunohistochemical studies revealed the presence of 5-HT-immunoreactivity in both mast cells and clusters of steroidogenic cells in APA tissues.
CONCLUSION: Our results show overexpression and different splicing of the 5-HT4 receptor in APA tissues in comparison with normal adrenocortical tissue. They also demonstrate the presence of 5-HT in both mast cells and tumor steroidogenic cells, providing evidence for a possible autocrine/paracrine activation of aldosterone secretion within adenoma tissues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16322401     DOI: 10.1530/eje.1.02051

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  18 in total

Review 1.  Diagnosis and treatment of primary aldosteronism.

Authors:  Paolo Mulatero; Silvia Monticone; Franco Veglio
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

Review 2.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

Review 3.  Toying with fate: Redirecting the differentiation of adrenocortical progenitor cells into gonadal-like tissue.

Authors:  Theresa Röhrig; Marjut Pihlajoki; Ricarda Ziegler; Rebecca S Cochran; Anja Schrade; Maximiliaan Schillebeeckx; Robi D Mitra; Markku Heikinheimo; David B Wilson
Journal:  Mol Cell Endocrinol       Date:  2014-12-08       Impact factor: 4.102

4.  Role of cAMP/PKA pathway and T-type calcium channels in the mechanism of action of serotonin in human adrenocortical cells.

Authors:  Estelle Louiset; Céline Duparc; Sébastien Lenglet; Celso E Gomez-Sanchez; Hervé Lefebvre
Journal:  Mol Cell Endocrinol       Date:  2016-10-12       Impact factor: 4.102

5.  Inhibitory effect of bufalin and cinobufagin on steroidogenesis via the activation of ERK in human adrenocortical cells.

Authors:  Mei-Mei Kau; Jiing-Rong Wang; Shiow-Chwen Tsai; Ching-Han Yu; Paulus S Wang
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

6.  PKA regulatory subunit 1A inactivating mutation induces serotonin signaling in primary pigmented nodular adrenal disease.

Authors:  Zakariae Bram; Estelle Louiset; Bruno Ragazzon; Sylvie Renouf; Julien Wils; Céline Duparc; Isabelle Boutelet; Marthe Rizk-Rabin; Rossella Libé; Jacques Young; Dennis Carson; Marie-Christine Vantyghem; Eva Szarek; Antoine Martinez; Constantine A Stratakis; Jérôme Bertherat; Hervé Lefebvre
Journal:  JCI Insight       Date:  2016-09-22

7.  Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues.

Authors:  C G Ziegler; J W Brown; A V Schally; A Erler; L Gebauer; A Treszl; L Young; L M Fishman; J B Engel; H S Willenberg; S Petersenn; G Eisenhofer; M Ehrhart-Bornstein; S R Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-27       Impact factor: 11.205

8.  Differential effects of high and low steroidogenic factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells.

Authors:  Ping Ye; Yashuhiro Nakamura; Enzo Lalli; William E Rainey
Journal:  Endocrinology       Date:  2008-10-30       Impact factor: 4.736

Review 9.  Understanding primary aldosteronism: impact of next generation sequencing and expression profiling.

Authors:  Silvia Monticone; Tobias Else; Paolo Mulatero; Tracy A Williams; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2014-09-18       Impact factor: 4.102

10.  Aldosterone is Aberrantly Regulated by Various Stimuli in a High Proportion of Patients with Primary Aldosteronism.

Authors:  Matthieu St-Jean; Isabelle Bourdeau; Marc Martin; André Lacroix
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.